Yüksel Ürün: Prognostic and predictive biomarkers in RCC by Payal Kapur

Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X:

“ Outstanding presentation at Kidney Cancer Research Summit 2024 (KCRS24).

•  Numerous prognostic and predictive biomarkers in Renal Cell Carcinoma (RCC) by Payal Kapur.
• Gene expression-based angiogenic and inflamed RCC subtypes correlate with therapy response.
• Challenges in RNA signatures and potential of morphology in therapy selection.”

Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.